Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CVT/Astellas Submit Next-Gen Cardiac Stress Agent Regadenoson

May 15 2007

• By Shirley Haley

Related Content

CVT/Astellas To Submit Regadenoson In Mid-2007, Following Successful Phase III Studies

Dec 04 2006

CVT’s Ranexa Approved For Second-Line Angina

Jan 27 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window